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7. Summary  
Examination of recumbent cows in consideration of the effectiveness of an additional 
therapy with an oral calcium phosphorus suspension 
In the following study 188 cows being recumbent or showing clinical symptoms of 
parturient paresis were treated. The clinical signs of the animals were collected on a paper. A 
blood sample was taken from each patient before treatment to find out clinical-chemical 
parameters. In the following the group of cows were randomly allocated into a test group and 
a control group. Additional to the standard therapy, the test group was fed an oral calcium 
phosphorus suspension which was supposed to be tested for its effectiveness on cows 
suffering from parturient paresis. The success of the treatment was documented in a paper. In 
the end clinical and clinical-chemical parameters were evaluated. Target of the study was to 
show changes in clinical signs of recumbent cows. The study shows a change in the 
prevalence of clinical symptoms of the recumbent cow. Most of the cows only showed little 
clinical signs. The parturient paresis occurred more frequently in elder animals. 4.8% of the 
patients were primiparous. Most animals (119 animals) were laying in sternal recumbency. A 
decrease in rectal temperature was recorded in only 28,2% of the animals. The temperature 
of the body surface was within normal limits in 48,4% of the patients and was only mildly 
reduced in the auricular region in 26,7% of the cows. 30 animals were lethargic. 34% of 
animals had a retained placenta. In this connection the study showed a higher risk for 
animals suffering from parturient paresis to suffer from a retained placenta, but there was no 
relationship between the occurrence of retained placenta and the serum calcium and serum 
phosphorus levels. The examination of the clinical-chemical parameters showed, that there 
were more patients with hypophosphataemia (75,0%) than patients with hypocalcaemia 
(69,1%). None of the primiparous animals was hypocalcaemic and hypophosphataemic at 
the same time. Three primiparous animals were hypocalcaemic and six hypophosphataemic. 
All but one animal being lethargic were hypocalcaemic. Lethargic patients had significantly 
decreased serumcalcium, higher glucose, creatinkinase and bilirubin values than cows 
without lethargy. 37,2% of the patients showed an increase of ß-hydroxybutyric acid 
concentrations and were suspected to be ketotic. The bilirubin concentration was 
pathologically increased in 40,4% of the patients.  
In consideration of the results of clinical-chemical examination the animals were placed in 
different groups representing different aetiology of the disease. Patients in group 1.1, which 
suffered from hypocalcaemia and hypophosphataemia, mostly showed severe hypocalcaemia 
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and hypophosphataemia. 19 animals were diagnosed with a single hypocalcaemia (group 
1.2). 30 animals were diagnosed with a single hypophosphataemia (group 1.3). 28 animals 
being normocalcaemic and normophosphataemic and suffering from other reasons were 
placed in the groups 2-4. Cows that needed further treatments showed significantly higher 
values in creatinekinase, AST and bilirubin than animals that were successfully treated by 
one infusion therapy. Patients that where treated successfully showed a decrease in 
creatinkinase and AST values. In contrast to these findings the initial calcium serum level 
and serum phosphorus level had no influence on the healing process. The total cure rate of 
cows with parturient paresis was 85,1%. 72,9% of the patients where successfully healed 
with the initial treatment, 12,2% of the patients where healed with further treatments. Cows 
suffering from atypical parturient paresis could be successfully healed with the first 
treatment only. If this initial treatment was ineffective, a success did not occurre with further 
treatments.  
The animals being divided into a test group and a control group for the examination of an 
oral calcium phosphorous suspension did not show any significant differences in clinical 
parameters. A significant decrease in serum chloride levels was found in the test group. All 
other clinical-chemical evaluations showed no difference in both groups. Therefore the 
results of both groups of animals can be compared without restriction. A significant 
improvement of the treatment could not be achieved by the administration of the oral 
phosphorus preparation. Due to the early gut stasis of animals suffering from parturient 
paresis the orally applied calcium and phosphorus could not be absorbed and therefore could 
not attain bioavailability in the diseased animal. The blood samples from control and test 
cows taken at three to six hours post the initial treatment showed no significant differences. 
Accordingly to this study the additional oral application of calcium and phosphorus did not 
improve the cure rate of recumbent cows in the peripartal period.  
 
 
 
 
 
 
 
 
 
 
 
